How to Tell When A Drug Company Fibs About Clinical Trial Results
July 3, 2012 | Reporter Adam Feurstein diligently dissects an upbeat official announcement from Osiris about its Prochymal heart attack study, parsing the language of clinical trial results while finding independent sources of truthful information, such as clinicaltrials.gov. "Interpreting clinical trial results with a skeptical eye is a crucial tool," writes Feuerstein, "... sadly and too often, bullish pronouncements about boffo clinical trial data are just spin jobs ginned up to plaster over problems and bad data." The Street
